Graft versus Host Disease GVHD mesenchymal stem cell treatment

Click here for trial sites near you.


Prochymal Clinical Trial Information for the Treatment of Crohn's Disease


Crohn's disease is a chronic, life-long condition with relapsing inflammation of the bowels and gastrointenstinal tract. Its fundamental cause is unknown, but it is suspected to come from a genetic predisposition of the body’s overreaction to the environment, items in the diet, or an infection. Severe Crohn's disease can cause pain, undesirable changes in lifestyle, hospitalizations, and side-effects from medications used for treatment. While Crohn's disease often first occurs in people between the ages of 20 and 30, it can occur in children or at any other age. In the majority of sufferers, it requires surgery at least once. Over 500,000 people in the U.S. are afflicted with Crohn's disease, and approximately 20,000 new cases are diagnosed each year.



Phase III trial is currently enrolling patients

Phase II results of Crohn's disease trial


Developing regenerative medicine technologies:

Prochymal is being evaluated in Crohn's disease, a disease that can cause disability, lost work time and nutritional deficiencies. Severe Crohn's disease may require surgery or hospitalization.